Hims Hims 2026 Earnings: Q1 Insights for Investors
An investor's guide to the early signals from hims 2026 earnings. We break down Q1 results, margins, and what they me...
When To Choose Bonds Over Index Funds In Retirement
Timing bond vs index fund choices in retirement affects risk and growth. Learn when to shift allocations for income.
25,546 articles
AI Rally Has Gone Too Far, Some Stocks Jump 70% in a Month
The AI rally has expanded beyond the marquee leaders, lifting a wider group of software and cybersecurity names. Anal...
Which Optics Stock Dominated in 2026: AAOI, LITE, COHR
As AI data centers expand, three optics names have led the charge in 2026. Through May, AAOI has surged, while LITE a...
Anduril Hires Rocket Help for Hypersonics Push Investors
As defense demand accelerates, Anduril Industries partnering with Rocket Lab to tackle hypersonics could reshape fund...
Evolv Technologies Stock Plummeted: Why It Dropped
Evolv Technologies stock plummeted after mixed results that still beat on revenue and nudged full-year guidance highe...
Paysign Pays 2026 Earnings: Q1 Review and Outlook Today
Investors are watching Paysign as it tees up Q1 2026 earnings. This article breaks down what to expect, key metrics t...
MapLight's Just Sold 36,000: What It Means for Investors
When a chief financial officer liquidates shares, investors pay attention. This article digs into maplight's just sol...
Bitcoin Depot Bankruptcy Shakes Bitcoin ATMs Empire
Bitcoin Depot, once the largest Bitcoin ATM network in North America, filed for Chapter 11 protection and began windi...
Bitcoin’s Price Drop Below 78K Triggers Hedge Bets
Bitcoin slid below 78,000 over the weekend, prompting a surge in downside hedging as traders priced in volatility and...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Target 2026 Earnings Call: What Investors Should Watch
As Target prepares for its Q1 2026 earnings call, savvy investors want clarity on sales growth, margins, and the path...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status